A recent report published by Infinium Global Research on proton
therapy market provides in-depth analysis of segments and sub-segments in the
global as well as regional proton therapy market. The study also highlights the
impact of drivers, restraints, and macro indicators on the global and regional
proton therapy market over the short term as well as long term. The report is a
comprehensive presentation of trends, forecast and dollar values of the global
proton therapy market. According to the report, the global proton therapy
market is expected to reach USD 1820 million in 2026, with a CAGR of 6.34%
during the forecast period 2020-2026.
Proton therapy also recognized as proton radiotherapy, usages
high-energy beams to treat tumors. The approach includes depositing a precision
dose of high energy radiation in the target tumor. It is extensively used in
the treatment of cancer. Furthermore, protons scatter less than other forms of
x-ray radiation, thus safeguarding less damage to the surrounding healthy
tissues. Moreover, proton therapy is used as a combination therapy with other
treatment methods. It offers numerous advantages such as precise targeting of
tumors and cancer cells, minimal exit dose, condensed overall toxicity. Rising
funding for cancer research is anticipated to offer lucrative growth
opportunities for players in the proton therapy market. Additionally, the
increasing number of healthcare facilities offering proton therapy is also
projected to aid in the growth of the market during the forecast period.
The global proton therapy market is mainly driven by snowballing
healthcare expenditure and growing preference for advanced therapies by
healthcare physicians. The increasing prevalence of cancer is anticipated to
propel the growth of the global proton therapy market over the projection
period. For example, as stated by the World Health Organization (WHO), around
18.1 million new cases, and 9.6 million deaths were registered due to cancer
across the world in the year 2018. On the other hand, pricing can become
restraining in the global proton therapy market, particularly when it comes to
the affordability of proton beam therapy devices by small hospital setups.
However, the introduction of proton therapy in developing economies is
estimated to offer lucrative growth opportunities for players in the market. In
addition, the development of compact machines is also projected to aid in the
growth of the proton therapy market.
Proton therapy devices presently available in the market involve a large
area for setting up. Thus, market players can focus on sinking the size of all
the parts in proton therapy devices.
Additionally, the current concern over the spread of coronavirus
is also projected to have a negative impact on the proton therapy market for
the short term. Various countries have initiated lockdowns and enforced
nationwide travel and trade restrictions. Further, the COVID-19 outburst has
impacted virtually every aspect of cancer care and research, from introducing
novel risks for cancer patients to troubling the delivery of cancer treatment
and the steadiness of cancer research. The main factors expected to exert an
impact on the proton therapy market include delay in outpatient hospital visits
for treatments, reduced healthcare spending, and delay in approval and launch
of new treatment therapies. The novel coronavirus is reshaping clinical trials
and delivery of cancer care broadly, and these changes might tolerate well
beyond the short- to mid-term of the active epidemic.
Among the geographies, the North America region is expected to
hold the largest share in the global proton therapy market owing to a surge in
funding for the research & development and healthcare infrastructure.
Further, factors such as an increase in the incidence of several cancers such
as stomach, lung, liver, colorectum, and esophagus are driving the proton
therapy market in the North America region. Furthermore, the Asia Pacific
region is projected to witness the fastest growth in the proton therapy market
during the forecast period owing to the rising healthcare infrastructure. In addition,
the rising awareness about the advanced treatment procedures and increasing
demand for healthcare facilities in emerging economies such as China and India
drive the proton therapy market in this region.
The report on global proton therapy market covers segments such as
system type, application, and end use. On the basis of system type, the
sub-markets include single room systems, and multi room systems. On the basis
of application, the sub-markets include prostate cancer, lung cancer,
colorectal cancer, pediatric cancer, and others. On the basis of end use, the
sub-markets include hospitals, ambulatory surgical centers, and specialty
The report provides profiles of the companies in the market such
as Hitachi Ltd., Ion Beam Applications SA, Mevion Medical Systems, Mitsubishi
Electric Corporation, ProNova Solutions, LLC, ProTom International, Sumitomo
Heavy Industries Ltd., Optivus Proton Therapy, Inc., Advanced Oncotherapy plc,
and Varian Medical Systems, Inc.
The report provides deep insights into the demand forecasts,
market trends, and micro and macro indicators. In addition, this report
provides insights into the factors that are driving and restraining the growth
in this market. Moreover, The IGR-Growth Matrix analysis given in the report
brings an insight into the investment areas that existing or new market players
can consider. The report provides insights into the market using analytical
tools such as Porter's five forces analysis and DRO analysis of proton therapy
market. Moreover, the study highlights current market trends and provides
forecast from 2020-2026. We also have highlighted future trends in the market
that will affect the demand during the forecast period. Moreover, the
competitive analysis given in each regional market brings an insight into the
market share of the leading players.